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Economic analysis of service and delivery interventions in
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: There are well-developed guidelines for economic evaluation of clearly defined clinical interventions,
but no such guidelines for economic analysis of service interventions. Distinctive challenges for analysis of
service interventions include diffuse effects, wider system impacts, and variability in implementation, costs
and effects. Cost-effectiveness evidence is as important for service interventions as for clinical interventions.
There is also an important role for wider forms of economic analysis to increase our general understanding
of context, processes and behaviours in the care system. Methods exist to estimate the cost-effectiveness
of service interventions before and after introduction, to measure patient and professional preferences, to
reflect the value of resources used by service interventions, and to capture wider system effects, but these
are not widely applied. Future priorities for economic analysis should be to produce cost-effectiveness
evidence and to increase our understanding of how service interventions affect, and are affected by, the
care system.
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Foreword
In 2016, the National Institute for Health Research (NIHR) Journals Library published a series of essays, inwhich a range of UK and international experts in health services research identified current developments
and future challenges in methods to evaluate health, social care and public health innovations. It was
recognised that this volume did not comprehensively address the full array of methods. One such gap was
the economic evaluation of service innovations. A meeting of recognised experts supported by NIHR
Collaborations for Leadership in Applied Health Research and Care, NIHR Health Services and Delivery
Research and the Medical Research Council was held in 2017 to address this area. Matt Sutton and
colleagues draw together here the key insights from that meeting. There are distinctive methodological
challenges in the economic evaluation of service innovations, not least that randomised controlled trials are
not usually feasible, and costs and benefits are diffuse and variable across the system. The authors provide
a clear and authoritative summary of solutions identified to date and an agenda of future challenges.
Ray Fitzpatrick
Professor of Public Health and Primary Care
University of Oxford
Oxford
UK.
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Scientific summary
Health economists consider a variety of topics and this includes the demand for care, the supply ofservices, the relationship between demand and supply, the efficiency and equity of service provision
and resource allocation, and the evaluation of clinical and service interventions, policy initiatives and
wholesale health system reorganisations. Health economists have developed a wide range of techniques
for economic evaluation of the relative costs and benefits of clinical interventions, but they also have an
important role to play in understanding and evaluating service interventions. Although not different in
principle from other forms of intervention, there are a number of distinctive issues that come to the fore
with service interventions, including dealing with non-randomised study designs, diffuse effects, wider
system impacts, and heterogeneity in implementation and impacts. Recent developments include methods
to produce aggregate estimates of programme impacts on patient health before and after introduction,
measure patient and professional preferences, and capture opportunity costs. Alongside evidence on
relative costs and benefits to inform decision-making, there is an important role for descriptive economic
analysis of service interventions to produce generalisable learning about the mechanics of the care system.
Future work should focus on producing evidence on cost-effectiveness, increasing our understanding of
the production process and the behaviour of agents in care systems, and contributing to interdisciplinary
process and outcome evaluations.
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Essay 9
Introduction
Some of the most important decisions that are made in health care are those concerning how services
should be configured and delivered. These decisions include how resources should be distributed between
areas, populations, programmes of care and settings; the location and accessibility of services; payment
systems and incentives; the size, composition and skills of the workforce; methods to improve compliance
with safety and effectiveness guidelines; and service specialisation, co-ordination and integration.
Collectively, these decisions constitute ‘service and delivery interventions’. For brevity, we refer to these as
‘service interventions’ for the remainder of this essay.
Recommended methods for the economic analysis of service interventions are less well articulated than for
other types of interventions and there are no comprehensive guidelines. The National Institute for Health
and Care Excellence (NICE) produced an interim methods guide for developing service guidance in 2014,1
which provided recommendations on how services should be organised around clinical interventions that
have been deemed clinically effective and cost-effective. Existing Medical Research Council (MRC) guidance
on complex interventions2 and natural experiments3 are primarily focused on evaluating effectiveness and
pay relatively little attention to economic issues. Other guides to economic appraisal are focused on
high-level policy evaluations.4,5
Several essays within this collection discuss pertinent issues for the economic analysis of service interventions.
Watson and Lilford (Essay 1 from Raine et al.6) explain how multiple forms of evidence along proposed
causal pathways can be synthesised to link service interventions to outcomes. Barratt et al. (Essay 2 from
Raine et al.6) highlight how trial methods have been developed to facilitate evaluation of complex
interventions and large-scale transformations of services. Gillies et al. (Essay 3 from Raine et al.6) describe
the battery of methods that can be used to model causal effects and address bias in observational data,
many of which emanate from econometrics.
In this essay, we focus on additional opportunities and challenges specifically for the economic analysis of
service interventions. We begin by highlighting the distinctive issues involved in the economic analysis of
service interventions. Many of these issues are also germane to economic analysis of diagnostics, clinical
interventions and public health initiatives, but loom larger for service interventions. We then describe
some challenges that these distinctive issues pose for economic analysis. Following this, using a range
of examples, we highlight recent methodological developments in the economic analysis of service
interventions. We conclude by identifying the key challenges and priorities for future research.
Scope and role for economic analysis
Health economics contains a wide range of topics. A recent classification of topics in health economics is
provided by Wagstaff and Culyer,7 based on an analysis of the main content of four decades of health
economics papers (Box 1). These include papers focusing primarily on the measurement and valuation of
health, methods for the economic evaluation of interventions, defining and measuring efficiency and
equity, demand for health care, supply of health services, human resources and equilibrating mechanisms
such as market mechanisms and waiting times. Many papers, of course, consider more than one topic.
In tackling each of these topics, health economists have developed a wide range of techniques that could
be drawn on for the economic analyses of service interventions.
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Overall, the purpose of such analyses is to guide decisions regarding efficient and fair resource allocation
to achieve social objectives, including enhancing overall population health and its distribution. Based on
the MRC framework for complex interventions,3 we can envisage four stages at which economic analysis
can support decision-making. These are the:
1. design stage
2. implementation stage
3. evaluation stage
4. translation stage.
These stages will not necessarily be sequential and will often interact. In some instances, the evaluation
stage may be very broad and involve implementation and translation elements, alongside the more
standard evaluation elements of effects estimation, evidence synthesis, assessment of trade-offs and
analysis of uncertainty.
At the design stage, economics is one of the disciplines that can contribute to the development of service
interventions. There are, for example, interventions that derive primarily from economic theory, such as the
form of health care financing8 and the design of financial incentives for care providers.9 Economic analysis
can contribute to the setting of prices in pay-for-performance systems.10 Financing and payment design
requires an understanding of the motivations of agents in the health-care system and how these agents
will respond to incentives and constraints. Payment design also requires an understanding of the
production process in health care, specifically which inputs are required, in what combinations and to what
scale, to produce desired outcomes. To put it more broadly, a deeper understanding of the production
process and the behaviour of agents in the care system should feed into the design of service and
delivery interventions.
At the implementation stage, the focus is on how the intervention will be introduced initially. Economic
analysis can contribute to clarifying the expected costs and benefits of the chosen intervention, identifying
where the key evidence gaps are and where prospective measurement should focus, and evaluating the
cost-effectiveness of different implementation strategies.11,12 At this stage, the ‘headroom method’13 of
economic analysis can be used to calculate the potential value of an intervention.14 In addition, there are
other approaches to providing an ex ante evaluation of the option value of a proposed intervention.
BOX 1 Twelve topics in health economics identified by Wagstaff and Culyer7
1. Health and its value.
2. Efficiency and equity.
3. Determinants of health and ill-health.
4. Public health.
5. Health and the economy.
6. Health statistics and econometrics.
7. Demand for health and health care.
8. Medical insurance.
9. Supply of health services.
10. Human resources.
11. Markets in health care.
12. Economic evaluation.
ESSAY 9
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At the evaluation stage, economic analysis can contribute to the specification and weighting of the
elements that will determine the overall cost-effectiveness of the intervention and to the estimation of the
cost and benefit consequences, and how these compare with opportunity costs (benefits that could be
achieved through alternative uses of the same resources). This may involve translating impacts on
intermediate end points into health gains [such as quality-adjusted life-years (QALYs)], incorporating other
relevant consequences (e.g. for equity) and identifying and measuring cost consequences. It will also
involve a formal assessment of uncertainty in the evidence and implications for decisions and the value of
further research, to inform considerations of scaling up and rolling out.
At the translation stage, the focus is on the implications of study results identified in one context for
service design in another context. The concern is with wider roll-out and embedding the intervention in
other health systems. This will make use of evidence to assist in this extrapolation, such as baseline data
and relative risks in the original and future context. It will also make use of information on the use of
inputs in natural unit rather than resources used at the context-specific unit costs. More broadly, the
purpose of economic analysis at this stage is to inform considerations of how the service intervention will
affect, and be affected by, the wider care system in which it will be introduced when adopted by other
sites or at different times. This will include considering resource constraints in practice, the unintended
consequences, spillovers onto other services and people, and the effects of changes in the use of inputs in
other contexts.
Distinctive issues in the economic analysis of service interventions
It is tempting to envisage a spectrum based on the level and scale of intervention from clinical
interventions to service interventions to policy interventions. This may suggest that the well-developed
methodological guidance on economic evaluation for clinical interventions could be carefully adapted for
service interventions. Economic analyses within clinical studies, for example, have included many of the
features pertinent to service interventions, including analysing the determinants of costs and outcomes
using regression analyses, eliciting preferences using economic approaches (such as discrete choice
experiments) and investigating economic issues affecting implementation.
Several papers have considered the extent to which economic evaluation of different forms of intervention
differ from a ‘typical Health Technology Assessment (HTA)’. These include public health,15 social care,16
antimicrobials,17 diagnostics,18 medical devices19 and genetics.20 Together, these papers highlight that there
is no typical HTA and, instead, there is a spectrum of challenges facing any form of evaluation. No
challenge is unique to service interventions and there are lessons that can be learned across the spectrum
of challenges facing analysts focusing in different areas.
This highlights that there is no clear demarcation between clinical interventions, service interventions and
policy interventions. But there are differences in emphasis and the degree to which particular challenges
are salient and have to be dealt with. There are a number of features that appear distinctive for service
interventions (Box 2) and affect the focus of the analysis required. Lilford et al.21 emphasise that,
although there are some service interventions that are focused on specific processes, more generic service
interventions and policy interventions have the potential to have an impact on several processes and hence
exhibit more diffuse effects across multiple outcomes. Watson and Lilford (Essay 1 from Raine et al.6) show
how such causal chains can be modelled.
These more generic service interventions are likely to have multiple effects on large patient populations,
which may each be small in size but aggregate to substantial effects. The difficulties of detecting and
measuring multiple small effects pose even more of a challenge for service interventions that affect
multiple providers, such as network or system interventions. The difficulty of detecting and measuring
effects for large populations often makes primary data collection prohibitively costly. As a result, there is
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often a reliance on observational data sets with the concomitant challenges of attribution and causality
and a need to synthesise multiple sources of evidence.
The consequences of service interventions at the level of the health-care provider are often more
substantial than for clinical interventions. The associated changes in costs are therefore more complex. It is
more frequently noted in the case of service interventions that they may free up resources for other use
but do not reduce expenditure. This is exactly the rationale for considering opportunity costs in an
economic evaluation rather than financial implications. Nonetheless, the usual assumption of using cost-
weighted utilisation as a means of estimating relevant opportunity costs may be too simplistic for some
service interventions. Average unit costs may not be accurate proxies for the implications of non-marginal
changes in resource utilisation.
Any form of intervention is likely to have wider system impacts. They may divert resources away from other
patients and/or free up resources for potential use by other patients. Beyond these direct effects on costs,
interventions may affect costs and benefits indirectly. They may generate spillovers onto other people or
other interventions if the tasks involved are substitutes or complements. They may also influence both the
demand side and the supply side of the production process. On the demand side, it is necessary to
understand patient preferences and how current and potential patients may respond to reconfigured
services. On the supply side, it is necessary to consider the capacity of the system in terms of the availability
of the required inputs. If it takes time for staff to be recruited or retained, there may be a period in which
demand exceeds supply and a lag before the system comes to an equilibrium. We know relatively little
about how different levels of labour input affect the capacity of the system in general. Moreover, the
effects on some inputs, especially labour, are behavioural. Little is known about how staff will respond to
increases or decreases for the demand for their input. There is substantial literature on the interaction
between supply and demand, often known as ‘supplier-induced demand’.22
A further set of distinctive features for service interventions relate to the heterogeneity of implementation,
context and impact between places and over time. Heterogeneity exists in the implementation and delivery
of the intervention, what sort of care the intervention is designed to replace and in the context into which
BOX 2 Distinctive features of service and delivery interventions
Diffuse effects
l Intervention is more distal to the patient and acts through multiple processes.
l Multiple, small effects across a wide range of patient outcomes.
Wider system impacts
l Demand-side effects.
l Supply-side effects.
l Spillovers.
l Equilibrium influences.
Variability
l Heterogeneity between organisations in implementation and effectiveness.
l Impact depends on context.
l Impact varies over time.
l Fast-paced nature of decision-making and changing wider context.
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the service innovation is introduced. Although these heterogeneity issues are also relevant for clinical
interventions, the narrower scope, tighter protocols and eligibility criteria for recruitment limit their
pertinence. Service interventions are not always clearly defined, they often evolve over time, and they may
not use strict criteria to define their target population. Consequently, the extent of variation between
organisations in how they implement service interventions is more substantial than clinical interventions.
Context is more important for service interventions as this affects impact. This may lead health-care
organisations to negotiate a range of variations and prices with providers for a given type of intervention,
such as was found in a recent study of electronic prescribing systems.23 The changing environment in
which service interventions take place, the dynamic nature of service interventions and the less formalised
decision-making process in service interventions are also distinctive features. The other essays in this
collection6 (especially Essays 6–8 from Raine et al.6) have also highlighted these issues.
Challenges for economic analysis of service interventions
Although randomised controlled trial (RCT) designs have been developed to evaluate complex interventions
and large-scale transformations of services (Essay 2 from Raine et al.6), economic analyses of service
interventions have tended to rely on non-experimental designs and observational data for practical reasons
of implementation and prohibitively high data collection costs. Gillies et al. (Essay 3 from Raine et al.6)
emphasise the challenges involved, including the requirements for risk adjustment and matching in
comparative evaluations. Nonetheless, these approaches based on observational data have advantages of
generalisability, more accurate reflection of routine practice and more comprehensive coverage than many
RCTs. It is likely that combinations of experimental and observational data will be the most informative.24
Irrespective of study design, it is important to seek a comprehensive understanding of how an intervention
works. Theoretical understanding can aid judgements concerning both the internal validity of findings and
their applicability to other contexts.21,25 In order to acquire or enhance such theoretical understanding, it is
desirable to collect information across a causal chain linking an ‘upstream’ intervention to its effect at the
patient level ‘downstream’ (Essay 1 from Raine et al.6).
The issue of how to allocate scarce resources and the notion of opportunity cost are ubiquitous to all
forms of intervention. Therefore, economic evaluations should also be fundamental to economic analyses
of service interventions. The fact that studies of clinical interventions are more often undertaken using
study designs with greater internal validity (e.g. multicentre RCTs) has enabled economists to focus on the
comparison of costs and benefits. Because evaluations of service interventions have tended to involve more
challenging non-experimental designs, economists have tended to focus on attribution and causality and
made important contributions to the robust estimation of impact. This is a matter of custom and practice,
but also capacity. Nonetheless, the questions of how service changes affect costs and patient benefits
remain important for service interventions and should be given more attention.
Evaluations of service delivery interventions often take place in a context where the service as a whole is
taking measures to improve the relevant aspect of care. The result is a secular trend or ‘rising tide’ that
might obscure the effects of an intervention in an evaluative study.26 Promising interventions that have
produced null results in such circumstances for which the system as a whole was undergoing rapid
improvement included the Safer Patient Initiative in the UK,27,28 the ‘Matching Michigan’ study to reduce
bloodstream infections29 and the Medical Early Response, Intervention and Therapy (MERIT) study to
improve recognition of deteriorating patients on the ward.30 In all these cases, there was evidence that the
system on a whole was improving alongside the introduction of the service intervention.
Service interventions frequently have consequences for the demand side of the health-care system. Patient
preferences, knowledge and constraints affect their choices and their behaviour. Service changes can
affect what is offered to patients and the costs they incur in accessing care. These can have knock-on
consequences for their use of services, for their families and carers31 and for their health behaviours.32–34
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All of these considerations contribute to the impact and the costs of service interventions and affect the
generalisability of evidence from one setting to another.
In considering the total cost of the intervention, it is important to distinguish the set-up costs, that are
incurred just once and may include research-only costs, from the running costs that would be expected in
perpetuity. Many service interventions, especially at the organisational level, incur high upfront or set-up
costs. These costs pose challenges for evaluation because they would ideally be shared over all users,
which means making decisions about the lifetime of the intervention and the number of patients affected
over the long term. They also pose a challenge for implementation because, even if the average cost per
patient is acceptable, commissioners or providers might not have the resources to meet the high
upfront costs.
There are also additional cost issues. The cost consequences may differ substantially between
organisations, for example because different amounts of time from different types of staff may be devoted
to the intervention. We may be interested in the impact that the scale of implementation has on costs.
Finally, there are likely to be cost consequences across organisations (e.g. from secondary to primary care)
and there may be differences between these organisations in their capacity to absorb additional costs.
Studies of service interventions often consider different study questions than whether or not the intervention
is better than usual care. In many cases, there is a focus on whether or not an evaluation of a service
intervention will provide generalisable evidence about whether or not a change to inputs or organisation
causes changes in delivery and/or outcomes. Thus, there is less desire for evidence on ‘if it worked’ and
more on the identification of causal relationships that can inform the design and implementation of future
interventions, as policy and practice will have moved on. This is in part because there is no requirement prior
to adoption to prove cost-effectiveness and less potential for roll-out of the same service in all contexts.
Therefore, the focus is not about informing a discrete decision and providing evidence to support wider
adoption, but on furthering understanding of the care system to inform future service changes.
As a consequence, there are two overall purposes for economic analysis of service interventions. As with
other forms of intervention, economic analysis has an important role to play in providing a guide to
decision-making by comparing costs and benefits and assessing relevant opportunity costs. But, in the case
of service interventions, economic analysis also provides descriptive analysis alongside decision-making to
help to understand processes rather than to evaluate decisions.
Recent developments
In this section we highlight some recent examples of methodological developments in the field of
economic analyses of service interventions.
Ex ante modelling of expected costs and benefits is an important aid to decision-making,13 the design of
service interventions and the design of future evaluations. Impact assessments were, for a period, routinely
undertaken by the Department of Health.35 They were a useful part of the policy formation process but
are, regrettably, no longer required. The analysis of the policy of introducing 7-day hospital services by
Meacock et al.,36 Brown and Lilford’s37 evaluation of a government directive to wash hospital wards, and
the evaluation of a proposed service to improve handover of patients between hospital and home by
Yao et al.14 are examples of this approach. Such ex ante assessments should be more routinely produced
for proposed service interventions.
Broadly speaking, there are two approaches to producing summative assessments of the costs and benefits
of entire programmes. The first involves direct estimation of the summative impacts through exploitation of
some experiment or other source of variation in implementation. The second involves modelling the causal
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chain through component processes to derive an aggregate measure where direct estimation is
not feasible.
A recent example of the first, direct approach was undertaken for the reconfiguration of stroke services.
Morris et al.38 used observational data and difference-in-differences techniques to examine the mortality
and length-of-stay changes associated with reconfiguration of stroke services in London and Manchester.
Hunter et al.39 constructed decision-analytic models using data from population-based stroke registers,
audits and published sources to show the service intervention reduced mortality for a reduced cost per
patient, predominantly as a result of reduced hospital length of stay. Meacock et al.40 showed how a
similar approach could be taken for the Advancing Quality pay-for-performance programme41 adopted in
the North West of England. They translated the mortality reductions identified by Sutton et al.41 into gains
in QALYs using a discounted and quality-adjusted life-expectancy tariff, and compared these to the costs
to reach conclusions on the scheme’s cost-effectiveness. This was later developed with survival analysis to
obtain more accurate estimates of the QALY gains.42
Watson and Lilford (Essay 1 from Raine et al.6) explain how the second approach can be parameterised.
This can involve evidence synthesis and analysis of large observational data sets to derive parameters to be
plugged into economic models. As an example, Elliott et al.43 combined adherence improvement and
intervention costs from a trial with Markov models for diseases targeted by the New Medicines Service
tracking the effect of increased adherence on patient outcomes and health-care costs. Bayesian network
approaches have also been developed.44 There is potential value in combining the direct and modelling
method processes.21 Modelling outcomes of economic interest is a topic of increasing interest and lessons
will be learned from the ongoing advances in decision-analytic modelling being developed by the
International Society for Pharmacoeconomics and Outcomes Research.45
There have also been advances in the measurement of patient and professional preferences that can
further our understanding of demand-side and supply-side responses to service interventions. Discrete
choice experiments have risen in popularity in a variety of applications,46 including examining patient
aspects, such as whether or not convenience matters,47 and professional preferences for location48 and
other aspects.49 There is renewed focus on their external validity.50–52 An alternative is to model revealed
preferences when available.53 In an innovative combination of data on stated preference and revealed
behaviour, Scott and Sivey54 have shown that a general practitioner’s strength of preference for income is
correlated with their response to competition.
Recent work has begun to analyse how variations in historic data on care expenditure and population
outcomes can help us to understand the value of resources that may be affected by service interventions.
The recent work on the cost-effectiveness threshold by Claxton et al.,55 for example, has produced
estimates of opportunity costs based on previous patterns of expenditure across the NHS in England. These
supply-side estimates can be contrasted with the demand-side values proposed by NICE. Coupled with the
analysis of variations in productivity across organisations by Castelli et al.,56 this has the potential to provide
us with organisation-specific estimates of the opportunity costs of additional investments required for
service interventions.
Another area in which there have been recent advances is in the economics of implementation in health
care. This literature is relevant to all interventions, but especially service interventions, which often incur
high upfront costs and may not be straightforward to implement, even if shown to be cost-effective.
For example, the literature on ‘policy cost-effectiveness’ argues that decision-makers should consider both
the costs and effectiveness of implementation as well as the cost-effectiveness of the innovation to be
implemented.57,58 This was applied to the Quality and Outcomes Framework by Walker et al.59
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Future challenges and priorities
In this section we highlight gaps in the current methods and suggest what we need to focus on in
future research.
Economic evaluation is one of the key contributions of health economics to decision-making. Methods for
the health economic evaluation of medical devices and technologies, including pharmaceutical products,
are well developed and integrated into the process of clinical commissioning and decision-making through
bodies such as NICE.60 However, economic evaluation has not been incorporated in such a way for other
important questions concerning health service expenditure such as staffing policies, primary and secondary
care organisation and integration, and patient safety interventions. It is debatable whether guidelines for
economic analysis of service interventions are feasible or appropriate. Regardless, it will not be a simple
issue of adapting the existing HTA methods to the evaluation of service interventions.
In Box 3, we set out an initial list of questions that analysts should consider when considering service
interventions. These affect the analyses that can be performed and whether or not the nature of the
service innovation suggests that special issues need to be considered. This list of questions could be
developed into a more systematic list of considerations.
A challenge common to economic evaluation of all forms of interventions is whether or not we need to
consider wider ‘outcomes’ beyond patient health, as captured by the QALY. Additional potential issues
include access, quality, patient experience, sustainability, equity, capability and population engagement.
It is widely accepted that these aspects are important, but it is less clear as to whether they are of value in
themselves or because they affect patient outcomes, how they should be measured and how they should
be traded off against health outcomes to derive a composite measure of programme benefit that can also
be reflected in terms of opportunity cost.
Another common challenge is developing advanced methods for evaluating impacts in a non-experimental
setting. This is the area of economic analysis of service interventions that is most advanced (Essay 3 from
Raine et al.6), but there remains a need for a better understanding of the assignment mechanism for
programme evaluation. We need to understand why some organisations and professionals tend to
participate and others do not. This is key to developing robust comparators for non-experimental
evaluations. Economists should be involved at the earliest stage of decisions about the implementation
(such as phased roll-out) of service interventions to ensure that the important end points are collected.
BOX 3 Questions for the economic analysis of service interventions
l What is known about the causal chain from the intervention to patient outcomes?
l Are there likely to be impacts beyond the patients targeted by the service intervention?
l Is the service intervention likely to have an impact on other work undertaken by the care professionals involved?
l Is the service intervention sufficiently large to affect the structure of costs?
l Will the service intervention have an impact on costs across organisations?
l Does the introduction of the service intervention provide an opportunity to produce generalisable learning
on the production process?
l Does the introduction of the service intervention provide an opportunity to produce generalisable learning
on the behaviour of agents in the care system?
l What is known about the participation process and how might this inform the design of the estimation of
programme impacts?
l How will different forms of analysis inform commissioners of services?
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The key components of an economic evaluation are identification, measurement and valuation of the costs
and benefits. The identification stage is intended to produce a comprehensive list of potential costs and
benefits, but this has tended not to be systematic, with economists focusing primarily on the challenging
issues of measurement and valuation. There is potential for complementary, parallel investigations to
identify (1) variables that are likely to be affected, (2) potential impacts elsewhere in a complex system,
(3) proposed mechanisms that might, for example, support the robustness of the approach to identify
causal effects, (4) heterogeneity in engagement by different groups of patients and professionals, and
(5) the boundaries of generalisability for a particular analysis. These will be best achieved by more active
engagement in interdisciplinary research.
There is a belief that the potential for financial profit has driven the faster development of guidelines for
the economic evaluation of medical devices and pharmaceuticals. The guidelines have sought to safeguard
the NHS from products that are not cost-effective. A similar impetus may emerge for the evaluation of
service interventions as the provider sector becomes more diverse.
There is a more basic challenge of how to capture the opportunity costs of service interventions, which are
likely to comprise the costs of implementing the service intervention, the costs of delivering the service
intervention and the impact that the service intervention has on consequent care costs. Further challenges
are that these costs may differ between organisations and over time, and that service interventions
are sufficiently large to cause non-marginal changes in resource use. Therefore, there is scope for
methodological work on evaluating the impact of service interventions on costs.
More fundamentally, there is a need for economic analysis of service interventions to further our
understanding of (1) the production process and (2) the behaviour of agents in care systems. These
considerations should feed into how evaluations are undertaken, future ex ante analyses and how service
interventions should be co-designed in the future. Service interventions provide an opportunity to generate
additional evidence on these issues by offering a purposive source of variation in care delivery. Through
these ‘experiments’, there is scope to develop and collate generalisable knowledge on the mechanisms
operating within the care system.
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